Cases in Practice: Applying Proposed Care Pathways for Interdisciplinary Collaboration to the Management of Nasal Polyps

Target Audience
The intended audience for this program is ENTs, allergists, immunologists, specialty nurse practitioners and physician assistants, and other clinicians involved in the management of patients with nasal polyps (NPs).

Program Overview
Clinicians on the frontlines of care for chronic rhinosinusitis with nasal polyps " including ear, nose, and throat specialists (ENTs) and allergists-- are largely unaware of the underlying pathophysiology driven by type 2 (T2) inflammation that leads to NPs and drives recurrent disease and treatment resistance. Yet understanding these mechanisms may be key to selecting appropriate treatment. Further, as the management of NPs has evolved, several organizations and professional societies, including professional rhinology organizations, have developed guidelines or consensus statements positioning the role of biologic agents in NP care.

Join a panel that includes an ear, nose, and throat specialist (ENT) and a representative from AAFA to discuss cases illustrating the adoption of biologics as a therapeutic option for NPs and the importance of multidisciplinary care. Panelists will review the underlying pathophysiology of NPs driven by type 2 (T2) inflammation that leads to NPs and drives recurrent disease and treatment resistance. The experts will also explore the place of biologics in NP care and share strategies to encourage collaboration among ENTs, allergists, and patients.

Learning Objectives
After completing this activity, the participant should be better able to:

Demonstrate ability to apply guidelines and expert recommendations to the management of severe, resistant NPs based on patient factors, including comorbidities, response to past treatments, and risk of recurrence
Discuss strategies for implementing interdisciplinary collaborative care between ENTs, allergists, and other members of the care team managing patients with NPs and T2‐driven comorbidities
Describe the shared inflammatory pathophysiology of NPs and common comorbidities